Similar articles

• NF1 Alterations are Linked to Increased HER2 Expression in Breast Cancer-Letter.

  Gambini D, Natacci F, Cesaretti C, Fusco N. Gambini D, et al. Cancer Prev Res (Phila). 2019 Mar;12(3):195-196. doi: 10.1158/1940-6207.CAPR-18-0392. Epub 2019 Feb 21. Cancer Prev Res (Phila). 2019. PMID: 30792346 No abstract available.
• Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.

  Anastasaki C, Woo AS, Messiaen LM, Gutmann DH. Anastasaki C, et al. Hum Mol Genet. 2015 Jun 15;24(12):3518-28. doi: 10.1093/hmg/ddv103. Epub 2015 Mar 18. Hum Mol Genet. 2015. PMID: 25788518 Free PMC article.
• [Pathogenic alterations within the neurofibromin gene in various cancers].

  Nagy Á, Garzuly F, Kálmán B. Nagy Á, et al. Magy Onkol. 2017 Dec 18;61(4):327-336. Epub 2017 Sep 5. Magy Onkol. 2017. PMID: 29257151 Review. Hungarian.
• The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data.

  Marrero D, Peralta R, Valdivia A, De la Mora A, Romero P, Parra M, Mendoza N, Mendoza M, Rodriguez D, Camacho E, Duarte A, Castelazo G, Vanegas E, Garcia I, Vargas C, Arenas D, Jimenez F, Salcedo M. Marrero D, et al. J Clin Pathol. 2012 May;65(5):419-23. doi: 10.1136/jclinpath-2011-200569. Epub 2012 Mar 12. J Clin Pathol. 2012. PMID: 22412049
• NF1 mutations and molecular testing.

  Thomson SA, Fishbein L, Wallace MR. Thomson SA, et al. J Child Neurol. 2002 Aug;17(8):555-61; discussion 571-2, 646-51. doi: 10.1177/088307380201700803. J Child Neurol. 2002. PMID: 12403553 Review.